ST-246 liquid formulations
View Patent ↗The present invention provides for a novel liquid formulation for solubilizing poorly soluble ST-246 in cyclodextrins and a novel process of making the formulation.
1. A liquid pharmaceutical formulation comprising a therapeutically effective amount of ST-246 and hydroxypropyl-β-cyclodextrin and/or sufobutyl-ether-β-cylodextrin, and further comprising one or more pharmaceutically acceptable ingredients.
2. The liquid pharmaceutical formulation of claim 1 , wherein said pharmaceutically acceptable ingredients are selected from the group consisting of carrier, excipient, diluent, additive, filler, lubricant and binder.
3. The liquid pharmaceutical formulation of claim 1 , wherein said hydroxypropyl-β-cyclodextrin is present in amounts from about 20% to about 40% by weight.
4. The liquid pharmaceutical formulation of claim 1 having a pH between about 3 and 10.
5. The liquid pharmaceutical formulation of claim 1 , wherein said hydroxypropyl-β-cyclodextrin has a degree of substitution of between about 4.0 to about 8.0.